Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) EBIT Margin: 2014-2024

Historic EBIT Margin for Collegium Pharmaceutical (COLL) over the last 11 years, with Dec 2024 value amounting to 26.91%.

  • Collegium Pharmaceutical's EBIT Margin rose 779.00% to 29.66% in Q3 2025 from the same period last year, while for Sep 2025 it was 20.74%, marking a year-over-year decrease of 1155.00%. This contributed to the annual value of 26.91% for FY2024, which is 255.00% down from last year.
  • According to the latest figures from FY2024, Collegium Pharmaceutical's EBIT Margin is 26.91%, which was down 8.67% from 29.46% recorded in FY2023.
  • Collegium Pharmaceutical's 5-year EBIT Margin high stood at 29.46% for FY2023, and its period low was 6.37% during FY2021.
  • In the last 3 years, Collegium Pharmaceutical's EBIT Margin had a median value of 26.91% in 2024 and averaged 21.18%.
  • Per our database at Business Quant, Collegium Pharmaceutical's EBIT Margin surged by 2,614bps in 2020 and then slumped by 1,177bps in 2021.
  • Over the past 5 years, Collegium Pharmaceutical's EBIT Margin (Yearly) stood at 18.14% in 2020, then slumped by 1,177bps to 6.37% in 2021, then soared by 81bps to 7.18% in 2022, then spiked by 2,228bps to 29.46% in 2023, then tumbled by 255bps to 26.91% in 2024.